Combination products for use in antitumoral treatment
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 3, 2005
app pub date -
May 17, 2005
filing date -
Jan 3, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
The invention concerns combination products comprising (i) at least a substance capable of inhibiting CSF-1 activity and/or at least a nucleic acid, comprising at least a sequence coding for a substance capable of inhibiting CSF-1 activity and (ii) at least a substance having a cytotoxic activity and/or at least a nucleic acid, comprising at least a sequence coding for a substance having cytotoxic activity. The invention also concerns oligonucleotides capable of inhibiting CSF-1 expression. The invention is particular useful for implementing an antitumoral treatment.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully